Nabriva Therapeutics(NBRV)

【仑胜医药】新型抗生素中国III期桥接试验成功！Nabriva股价大涨40%

医药魔方2021-05-27 10:20

5月25日，仑胜医药和Nabriva公司宣布，在中国开展的lefamulin（醋酸截短侧耳素）用于治疗成人社区获得性细菌性肺炎（CABP）的III期桥接试验取得积极结果。受此消息影响Nabriva股价大涨40%。
Lefamulin最初由Nabriva开发，2018年3月仑胜医药获得在大中华区，包括中国大陆、香港、澳门、台湾开...查看全文

fffffffooooo2021-05-27 03:26

$Nabriva Therapeutics(NBRV)$今天做空可以，跌一晚上查看全文

清風竹影2021-05-26 23:51

$Nabriva Therapeutics(NBRV)$ 是时候该拉了……查看全文

鲜克有终72021-02-11 03:44

$Nabriva Therapeutics(NBRV)$ [跪了]12➕查看全文

有为的股价小宝石2020-12-26 02:38

$Nabriva Therapeutics(NBRV)$ @小秘书 这个合股了麻烦改一下查看全文

conkers2020-07-30 12:43

$Nabriva Therapeutics(NBRV)$ 这家伙现在都这价格了查看全文

是毛哥没错2020-07-17 22:30

$Nabriva Therapeutics(NBRV)$ 看分析马上要飞了查看全文

kev88872020-07-17 21:56

$Nabriva Therapeutics(NBRV)$$纳斯达克综合指数(.IXIC)$
劲揪 ✅✅✅查看全文

kev88872020-07-17 01:30

$Nabriva Therapeutics(NBRV)$$纳斯达克综合指数(.IXIC)$
Ⅴ时段查看全文

$Nabriva Therapeutics(NBRV)$ 8-K - Current report Filed: 2019-09-26 AccNo: 0001104659-19-051550 Size: 35 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Re...

$Nabriva Therapeutics(NBRV)$ 8-K - Current report Filed: 2019-09-09 AccNo: 0001104659-19-049328 Size: 84 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$Nabriva Therapeutics(NBRV)$ 内部交易: 2019-08-30,Director,Broom Colin MD ,买入,10177普通股, $2.03

$Nabriva Therapeutics(NBRV)$ 内部交易: 2019-08-27,CEO,Schroeder Theodore R ,买入,50000普通股, $1.79

$Nabriva Therapeutics(NBRV)$ 内部交易: 2019-08-22,Chief Commercial Officer,Lavino Francesco Maria ,买入,4800普通股, $2.04

$Nabriva Therapeutics(NBRV)$ 8-K - Current report Filed: 2019-08-19 AccNo: 0001104659-19-046525 Size: 4 MBItem 7.01: Regulation FD DisclosureItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$Nabriva Therapeutics(NBRV)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-08-14 AccNo: 0001615774-19-011241 Size: 101 KB 网页链接

$Nabriva Therapeutics(NBRV)$ 8-K - Current report Filed: 2019-08-08 AccNo: 0001104659-19-044731 Size: 190 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$Nabriva Therapeutics(NBRV)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-08 AccNo: 0001104659-19-044881 Size: 6 MB 网页链接

$Nabriva Therapeutics(NBRV)$ 8-K - Current report Filed: 2019-08-05 AccNo: 0001104659-19-043927 Size: 50 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接